Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma

Fibroblast growth factor receptor 3 (FGFR3) is expressed in squamous cell carcinoma of the head and neck (SCCHN) including oropharyngeal squamous cell carcinoma (OPSCC) and is a potential therapeutic target. However, information on its correlation with other relevant cancer related proteins stratifi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Nannapaneni, Sreenivas, Griffith, Christopher C., Magliocca, Kelly R., Chen, Wanqi, Lyu, Xueying, Chen, Zhengjia, Wang, Dongsheng, Wang, Xu, Shin, Dong M., Chen, Zhuo G., Saba, Nabil F.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904228/
https://ncbi.nlm.nih.gov/pubmed/33626078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247498
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars